Combination therapy of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer: JFMC27–9902 phase I trial

Bunzo Nakata,Akihito Tsuji,Yasushi Mitachi,Yamamitsu S,Koichi Hirata,Tetsuhiko Shirasaka,Shigetoyo Saji,Kiyoshi Inokuchi,Kosei Hirakawa

Combination therapy of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer: JFMC27–9902 phase I trial

2004

Bunzo Nakata
Akihito Tsuji
Yasushi Mitachi
Yamamitsu S
Koichi Hirata
Tetsuhiko Shirasaka
Shigetoyo Saji
Kiyoshi Inokuchi
Kosei Hirakawa

4128 Background: The Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC) conducted a phase I trial to examine the tolerability, clinical efficacy, and serum concentration of 5-FU a...

Keywords:

Recurrent gastric cancer
Cisplatin
Fluorouracil
Oncology
Combination therapy
Medicine
Internal medicine
clinical efficacy
Cancer
low dose
Tolerability

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations